Skip to main content
. 2022 Oct 4;9:1018320. doi: 10.3389/fsurg.2022.1018320

Table 4.

Overall survival and lung cancer-specific survival for people treated using different methods.

Treatment Surgery only Radiation only Surgery + Radiation No treatment
Over survival
N 2,149 3,207 81 1,608
 Median survival (95% CI; months) 58 (56–62) 31 (29–32) 36 (27–52) 10 (9–11)
 1-year survival (95% CI) 86.79% (85.37%–88.24%) 78.04% (76.62%–79.48%) 80.25% (72.03%–89.40%) 44.94% (43.56%–47.44%)
 5-year survival (95% CI) 48.73% (46.32%–51.26%) 22.84% (21.02%–24.82%) 31.92% (22.12%–46.07%) 9.46% (7.91%–11.32%)
Lung cancer-special survival
N 2,149 3,207 81 1,608
 Median survival (95% CI, months) 61 (57–67) 32 (30–34) 38 (25–56) 11 (10–13)
 1-year survival (95% CI) 87.65% (86.09%–89.23%) 78.95% (77.11%–80.84%) 80.95% (71.82%–91.25%) 46.89% (43.48%–50.56%)
 5-year survival (95% CI) 50.25% (47.54%–53.11%) 24.62% (22.20%–27.30%) 31.05% (20.09%–48.00%) 11.02% (8.67%–14.00%)

CI, Confidence interval.